A Practice Note discussing the Food and Drug Administration's (FDA) general regulatory framework for foods, dietary supplements, and cosmetics under the Federal Food, Drug, and Cosmetic Act (FDCA) and how the FDA's approval of the drug Epidiolex affects the legal status of these products if they contain added cannabidiol (CBD). This resource also discusses FDA and Federal Trade Commission (FTC) enforcement actions against companies marketing CBD-containing foods, dietary supplements, and cosmetics.